| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.65▼ | 9.65▼ | 9.65▼ | 8.72▲ | 8.33▲ |
| MA10 | 9.57▼ | 9.32▲ | 9.13▲ | 8.34▲ | 10.00▼ |
| MA20 | 8.76▲ | 8.66▲ | 8.53▲ | 8.17▲ | 13.88▼ |
| MA50 | 8.25▲ | 8.40▲ | 8.52▲ | 10.11▼ | 13.01▼ |
| MA100 | 9.06▲ | 9.51▼ | 9.97▼ | 14.22▼ | 7.21▲ |
| MA200 | 11.13▼ | 12.71▼ | 13.84▼ | 15.31▼ | 5.56▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.091▲ | 0.140▲ | 0.188▲ | 0.370▲ | -0.920▼ |
| RSI | 58.882▲ | 58.692▲ | 58.320▲ | 53.630▲ | 40.087▼ |
| STOCH | 74.408 | 86.553▲ | 87.202▲ | 47.826 | 10.728▼ |
| WILL %R | -26.984 | -26.984 | -26.984 | -41.096 | -83.700▼ |
| CCI | 20.699 | 29.875 | 38.954 | 158.311▲ | -63.069 |
|
Thursday, August 06, 2026 06:40 AM
Rare-endocrine buyers have paid roughly $2.9 billion and approximately $10.0 billion for acquisitions in this area over the past four months. IMCIVREE, the only approved MC4R agonist for acquired ...
|
|
Tuesday, May 19, 2026 04:04 PM
Palatin Technologies ( (PTN)) has issued an announcement. Palatin Technologies, Inc., a biopharmaceutical developer of melanocortin receptor–targeted drugs, announced on May 18, 2026 that it will ...
|
|
Tuesday, May 12, 2026 04:59 PM
In 2012, Novo Nordisk (NYSE:NVO) had a once-weekly version of liraglutide, the molecule behind its diabetes drug Victoza, already in early-stage human trials. The trials had confirmed the drug was ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/08/26 | 10.27 | 10.27 | 8.8091 | 9.36 | 12,241 |
| 13/08/26 | 9.50 | 10.86 | 9.50 | 10.00 | 44,325 |
| 12/08/26 | 7.6274 | 9.58 | 7.2701 | 9.47 | 177,469 |
| 11/08/26 | 7.74 | 7.74 | 7.3701 | 7.41 | 6,737 |
| 10/08/26 | 7.76 | 8.20 | 7.28 | 7.36 | 12,726 |
| 07/08/26 | 8.30 | 8.30 | 7.451 | 7.77 | 18,120 |
| 06/08/26 | 8.35 | 8.3999 | 7.61 | 7.8701 | 4,361 |
| 05/08/26 | 8.34 | 8.4503 | 7.60 | 7.94 | 8,018 |
| 04/08/26 | 8.00 | 8.055 | 7.91 | 8.01 | 10,973 |
| 03/08/26 | 7.925 | 8.23 | 7.8301 | 8.23 | 12,295 |
|
|
||||
|
|
||||
|
|